APP and Cognitive impairment: We have identified marked sex-related differences in microglial activation, morphology, metabolism and function in APP/PS1 mice and we propose that these linked changes contribute to the more marked amyloid pathology, reduced neuroprotection and more profound cognitive impairment in females.